{"id":"https://openalex.org/W2923702829","doi":"https://doi.org/10.1080/19420862.2019.1583996","title":"Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency","display_name":"Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency","publication_year":2019,"publication_date":"2019-03-21","ids":{"openalex":"https://openalex.org/W2923702829","doi":"https://doi.org/10.1080/19420862.2019.1583996","mag":"2923702829","pmid":"https://pubmed.ncbi.nlm.nih.gov/30898021","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6601544"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2019.1583996","doi":"https://doi.org/10.1080/19420862.2019.1583996","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2019.1583996","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1583996?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1583996?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Chen Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chen Chen","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056916028","display_name":"Tetsuya Wakabayashi","orcid":"https://orcid.org/0000-0001-9547-1291","observed_orcids":["https://orcid.org/0000-0001-9547-1291"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuya Wakabayashi","raw_affiliation_strings":["Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan"],"raw_orcid":"https://orcid.org/0000-0001-9547-1291","affiliations":[{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089548236","display_name":"Masaru Muraoka","orcid":"https://orcid.org/0000-0002-6559-9785","observed_orcids":["https://orcid.org/0000-0002-6559-9785","https://orcid.org/0000-0002-5186-420X"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaru Muraoka","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-6559-9785","affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101046512","display_name":"Shu Feng","orcid":"https://orcid.org/0009-0009-3844-7450","observed_orcids":["https://orcid.org/0009-0009-3844-7450"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Feng Shu","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006122936","display_name":"Chia Wei Shan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chia Wei Shan","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066723447","display_name":"Chong Chor Kun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chong Chor Kun","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039032648","display_name":"Ching Tim Jang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ching Tim Jang","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091281403","display_name":"Ishin Soehano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ishin Soehano","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069199599","display_name":"Yuichiro Shimizu","orcid":"https://orcid.org/0000-0002-1329-7259","observed_orcids":["https://orcid.org/0000-0002-1329-7259"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuichiro Shimizu","raw_affiliation_strings":["Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1329-7259","affiliations":[{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Antibody Generation Group, Research Division, Chugai Pharmabody Research Pte. Ltd, Singapore","institution_ids":[]},{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005341632","display_name":"Tomoyuki Igawa","orcid":"https://orcid.org/0000-0003-0097-8220","observed_orcids":["https://orcid.org/0000-0003-0097-8220"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I4405277167","display_name":"Synapxe","ror":"https://ror.org/01q1qh982","country_code":"SG","type":"company","lineage":["https://openalex.org/I4405277167"]}],"countries":["JP","SG"],"is_corresponding":true,"raw_author_name":"Tomoyuki Igawa","raw_affiliation_strings":["Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","Research Division, Chugai Pharmabody Research Pte. Ltd","Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan","Research Division, Chugai Pharmabody Research Pte. Ltd., Synapse, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Research Division, Chugai Pharmabody Research Pte. Ltd","institution_ids":[]},{"raw_affiliation_string":"Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Research Division, Chugai Pharmabody Research Pte. Ltd., Synapse, Singapore","institution_ids":["https://openalex.org/I4405277167"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037890383","display_name":"Jun\u2010ichi Nezu","orcid":"https://orcid.org/0000-0003-0476-1264","observed_orcids":["https://orcid.org/0000-0003-0476-1264"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun-Ichi Nezu","raw_affiliation_strings":["Research Division, Chugai Pharmaceutical Co., Ltd","Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005341632","https://openalex.org/A5069199599"],"corresponding_institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I4405277167"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":0.7325,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.64737943,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"4","first_page":"632","last_page":"638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antibody-purification","display_name":"antibody purification","score":0.6259999871253967},{"id":"https://openalex.org/keywords/conductivity-control","display_name":"conductivity control","score":0.5920000076293945},{"id":"https://openalex.org/keywords/affinity-capture","display_name":"affinity capture","score":0.6539999842643738},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.6940000057220459},{"id":"https://openalex.org/keywords/fusion-protein","display_name":"fusion protein","score":0.6320000290870667},{"id":"https://openalex.org/keywords/biopharmaceutical-manufacturing","display_name":"biopharmaceutical manufacturing","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C139007053","wikidata":"https://www.wikidata.org/wiki/Q1412952","display_name":"Valency","level":2,"score":0.7704322338104248},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.7398906946182251},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6367517709732056},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6131799817085266},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.5514413714408875},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5184292793273926},{"id":"https://openalex.org/C179247698","wikidata":"https://www.wikidata.org/wiki/Q382799","display_name":"Affinity chromatography","level":3,"score":0.4542026221752167},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.36269715428352356},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24781262874603271},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1796392798423767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09601712226867676},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.09461453557014465},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001426","descriptor_name":"Bacterial Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002846","descriptor_name":"Chromatography, Affinity","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004553","descriptor_name":"Electric Conductivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007475","descriptor_name":"Ion Exchange Resins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015202","descriptor_name":"Protein Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D057127","descriptor_name":"Single-Chain Antibodies","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D057127","descriptor_name":"Single-Chain Antibodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/19420862.2019.1583996","doi":"https://doi.org/10.1080/19420862.2019.1583996","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2019.1583996","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1583996?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmid:30898021","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30898021","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6601544","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6601544/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1080/19420862.2019.1583996","doi":"https://doi.org/10.1080/19420862.2019.1583996","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2019.1583996","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1583996?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2923702829.pdf","grobid_xml":"https://content.openalex.org/works/W2923702829.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1451383000","https://openalex.org/W1461624625","https://openalex.org/W1485948483","https://openalex.org/W1921660070","https://openalex.org/W1966286047","https://openalex.org/W1966879395","https://openalex.org/W1968924601","https://openalex.org/W1981730803","https://openalex.org/W1984400438","https://openalex.org/W2010948143","https://openalex.org/W2011766387","https://openalex.org/W2012434595","https://openalex.org/W2015415511","https://openalex.org/W2016630133","https://openalex.org/W2056319576","https://openalex.org/W2060189702","https://openalex.org/W2084556679","https://openalex.org/W2112247421","https://openalex.org/W2165238581","https://openalex.org/W2209597121","https://openalex.org/W2293788518","https://openalex.org/W2571138221","https://openalex.org/W2593483585","https://openalex.org/W2597907100","https://openalex.org/W2602095186","https://openalex.org/W2747396160","https://openalex.org/W2762388141","https://openalex.org/W2784605149","https://openalex.org/W2790375884","https://openalex.org/W4230744147","https://openalex.org/W4293253343"],"related_works":["https://openalex.org/W168799647","https://openalex.org/W3134267027","https://openalex.org/W2125667994","https://openalex.org/W2092416180","https://openalex.org/W4388461511","https://openalex.org/W1975330632","https://openalex.org/W1683601423","https://openalex.org/W4311148159","https://openalex.org/W4416408932","https://openalex.org/W4297042476"],"abstract_inverted_index":{"The":[0],"complex":[1],"molecular":[2],"formats":[3,142],"of":[4,20,29,59,84,116],"recent":[5],"therapeutic":[6],"antibodies,":[7,10],"including":[8],"bispecific":[9],"antibody":[11,141],"fragments,":[12],"and":[13,33,66,110,145],"other":[14],"fusion":[15],"proteins,":[16],"makes":[17],"the":[18,22,45,50,60,77,88,94,102,114,125,131],"task":[19],"purifying":[21,139],"desired":[23],"molecules":[24],"in":[25,44],"a":[26,73],"limited":[27],"number":[28,115],"purification":[30],"steps":[31],"more":[32,34],"challenging.":[35],"Manufacturing":[36],"these":[37],"complicated":[38],"biologics":[39],"can":[40,121],"be":[41,122,136],"substantially":[42],"improved":[43],"affinity":[46],"capture":[47],"stage":[48],"if":[49],"simple":[51],"bind-and-elute":[52],"mode":[53],"is":[54],"accompanied":[55],"by":[56,91,127],"targeted":[57,106],"removal":[58],"impurities,":[61],"such":[62],"as":[63],"mis-paired":[64,109],"antibodies":[65,107],"oligomers":[67],"or":[68],"aggregates.":[69],"Here,":[70],"we":[71],"report":[72],"method,":[74],"based":[75],"on":[76],"binding":[78,119],"valency":[79],"to":[80,129],"Protein":[81,117],"L":[82,118],"resin,":[83],"separating":[85],"proteins":[86],"during":[87],"elution":[89],"step":[90],"simply":[92],"controlling":[93],"conductivity":[95],"at":[96,143],"low":[97],"pH.":[98],"We":[99],"show":[100],"that":[101],"method":[103,134],"efficiently":[104],"separated":[105],"from":[108],"aggregated":[111],"species.":[112],"Notably,":[113],"sites":[120],"built":[123],"into":[124],"molecule":[126],"design":[128],"facilitate":[130],"purification.":[132],"This":[133],"may":[135],"useful":[137],"for":[138],"various":[140],"laboratory":[144],"manufacturing":[146],"scales.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2019-04-01T00:00:00"}